ZELBORAF

Identification of Zelboraf

No description

Google image searchProduct monograph

Active ingredient

vemurafenib, 240 MG

DIN: 02380242

Dosage form(s): TABLET

Route(s) of administration: ORAL

Description: FILM-COATED TABLET

Schedule: Prescription

Company: HOFFMANN-LA ROCHE LIMITED

Date: 05-MAR-2012

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EC — B-Raf serine-threonine kinase (BRAF) inhibitors (ATC, ATC/DDD)
• L01EC01 — VEMURAFENIB (ATC/DDD)

Reference brand drug: Zelboraf

External Links for Zelboraf

Search on Google

• Zelboraf side effects
• Zelboraf dosage
• vemurafenib side effects
• vemurafenib dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find zelboraf photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.